ASML’s Missing Quarter Leaves a 68 Times Earnings Price

The central fact in this update is an evidentiary gap: no quarterly financial rows and no earnings press release were supplied. Consequently, the latest quarter's revenue, EPS, free cash flow, gross margin and operating margin are not disclosed in the available record. Prior company guidance is also unavailable, and the same quarter a year earlier is absent. Under the stated comparison rules, no beat or miss can be established for any of the five report-card metrics.

This distinction matters because annual results cannot be presented as though they were the latest quarter. FY2025 revenue was $32.67 billion, up 15.6% from FY2024. Gross margin improved to 52.8% from 51.3%, while operating margin increased to 34.6% from 31.9%. EPS rose to $24.71 from $19.24, and free cash flow increased to $11.08 billion from $9.10 billion. These are meaningful annual improvements, but the supplied information does not show whether that momentum persisted, accelerated or reversed in the newly reported period.

The annual balance sheet remained a source of resilience. FY2025 cash was $12.92 billion against $2.71 billion of debt, producing net debt of negative $10.21 billion, or net cash of the same amount. ROIC reached 40.0%, compared with 32.2% in FY2024. Again, neither metric has a supplied quarterly update, so the appropriate conclusion is that the last verified baseline is strong rather than that the latest print was strong.

There is also no management guidance to assess. The materials contain no revenue outlook, margin range, order commentary, capital-spending plan or statement about customer demand. Recent headlines may shape market expectations, but headlines are not a replacement for company-reported figures and are not used here to infer the quarter's performance. The report-card impact is therefore Neutral: not because operations necessarily stood still, but because the claimed change cannot be measured from the evidence provided.

ASML's verified FY2025 record supports the quality side of the thesis. Revenue growth of 15.6%, a 52.8% gross margin, a 34.6% operating margin and 40.0% ROIC describe a business with high profitability and strong returns on invested capital. Free cash flow represented a substantial conversion of operating earnings, and the net-cash position limits financing risk. Those features can justify a premium valuation relative to an ordinary machinery company.

The problem is the size of the premium already embedded in the share price. At $1,687.517, the shares trade at approximately 68.3 times FY2025 EPS of $24.71. The market capitalization is $656.3 billion, while FY2025 free cash flow of $11.08 billion implies a 1.7% trailing free-cash-flow yield. A low yield is not automatically excessive for a company capable of compounding rapidly, but it leaves little protection if growth slows, margins normalize or the valuation multiple contracts.

The missing quarter therefore matters asymmetrically. A strong update could validate the expectation that FY2025's growth and margin gains are durable. A merely adequate quarter might not be sufficient because the current valuation requires more than stable performance. Conversely, evidence of weaker demand, lower margins or rising capital intensity could have a disproportionate effect on fair value even if the long-term competitive position remained intact.

No thesis upgrade is justified without quarterly evidence. The annual record still indicates high business quality, but the valuation case remains demanding. The burden of proof sits with future earnings growth: balance-sheet strength can absorb operating volatility, yet it cannot prevent shareholders from experiencing multiple compression if reported earnings fail to catch up with the price.

Because no verifiable print was supplied and there is no prior SageNoodle valuation, this update establishes a provisional framework rather than changing an existing fair value. The method applies explicit price-to-earnings multiples to FY2025 EPS of $24.71. This is a deliberately simple approach necessitated by the absence of quarterly guidance, forward earnings, order data and segment forecasts. Each multiple is an assumption, not a company forecast.

The bear case applies 35 times FY2025 EPS, producing fair value of $864.85. This scenario assumes that the annual earnings base remains relevant but that slower growth, cyclical pressure or weaker evidence of margin durability causes a substantial premium to unwind. The multiple remains above that of a conventional machinery business because FY2025 still showed a 40.0% ROIC, high margins and net cash.

The base case applies 50 times FY2025 EPS, producing fair value of $1,235.50. This assumes ASML retains a material quality premium and that FY2025 profitability is broadly durable, while refusing to capitalize unverified quarterly acceleration. The base value is 26.8% below the current price, meeting the stated definition of Overvalued because fair value is less than 85% of the market price.

The bull case applies 70 times FY2025 EPS, producing fair value of $1,729.70. That outcome effectively assumes the market continues to award an exceptional multiple because future disclosures confirm sustained growth and premium returns. Even this case offers only about 2.5% upside from the supplied price. With scenario probabilities of 25% bear, 50% base and 25% bull, the probability-weighted cross-check is approximately $1,266.39, although the published fair value remains the required base-case value of $1,235.50.

EV/EBITDA is shown as zero in the structured snapshot solely because EBITDA was not supplied and the schema requires a numeric field; it should be read as not disclosed, not as an economic multiple of zero. The valuation should be revisited when a complete quarterly release provides a current earnings base, guidance and enough operating detail to determine whether a forward multiple or cash-flow model is better supported.

The cautious conclusion could be too negative if the omitted quarter contains a material acceleration in revenue, EPS and cash generation. At the current price, the market may be discounting earnings well above FY2025's $24.71 per share. A verified increase in the earnings base would reduce the effective multiple and could support a higher fair value without requiring an even richer valuation assumption.

Sustained or expanding margins would also challenge the base case. FY2025 gross margin of 52.8% and operating margin of 34.6% were both above FY2024 levels. If subsequent quarters demonstrate that these improvements are durable while revenue continues to grow at a double-digit rate, the 50 times base multiple could prove too conservative. The supplied materials, however, contain no quarterly evidence with which to make that judgment today.

The opposite risk is that FY2025 represented a favorable point in a cyclical sequence. ASML's annual free cash flow has varied considerably, ranging from $3.29 billion in FY2023 to $9.10 billion in FY2024 and $11.08 billion in FY2025. A reversal in cash conversion, higher capital expenditure or weaker operating margins would make the 1.7% trailing free-cash-flow yield look still less protective.

Finally, the disclosure gap itself can lead to analytical error. Without quarterly product mix, geography, customer exposure, orders or guidance, neither operating concentration nor execution risk can be measured properly. The thesis should change when primary company evidence changes—not when external headlines become more optimistic or pessimistic. Until a complete release is available, the strongest grounded conclusion is that ASML remains a high-return business priced for an outcome close to the upper end of this valuation range.